Index RUT
P/E -
EPS (ttm) -0.44
Insider Own 11.58%
Shs Outstand 74.96M
Perf Week 6.37%
Market Cap 4.55B
Forward P/E 83.67
EPS next Y 0.72
Insider Trans -1.19%
Shs Float 66.90M
Perf Month 21.86%
Income -32.35M
PEG -
EPS next Q 0.12
Inst Own 93.37%
Short Float 10.96%
Perf Quarter -1.30%
Sales 1.87B
P/S 2.43
EPS this Y 121.67%
Inst Trans 1.13%
Short Ratio 7.80
Perf Half Y -26.53%
Book/sh 11.98
P/B 5.06
EPS next Y 717.67%
ROA -1.03%
Short Interest 7.33M
Perf Year 4.16%
Cash/sh 9.56
P/C 6.34
EPS next 5Y -
ROE -3.65%
52W Range 45.00 - 93.65
Perf YTD -13.14%
Dividend Est. -
P/FCF 58.41
EPS past 5Y -33.78%
ROI -1.26%
52W High -35.23%
Beta 1.46
Dividend TTM -
Quick Ratio 2.01
Sales past 5Y 10.11%
Gross Margin 4.42%
52W Low 34.80%
ATR (14) 2.43
Dividend Ex-Date -
Current Ratio 2.01
EPS Y/Y TTM -231.18%
Oper. Margin 4.42%
RSI (14) 70.99
Volatility 3.79% 3.99%
Employees 8546
Debt/Eq 1.94
Sales Y/Y TTM 12.76%
Profit Margin -1.73%
Recom 1.17
Target Price 72.00
Option/Short Yes / Yes
LT Debt/Eq 1.85
EPS Q/Q -1171.57%
Payout 0.00%
Rel Volume 0.58
Prev Close 61.14
Sales Surprise 6.38%
EPS Surprise -287.60%
Sales Q/Q 9.19%
Earnings May 12 BMO
Avg Volume 939.82K
Price 60.66
SMA20 11.05%
SMA50 17.00%
SMA200 -5.01%
Trades
Volume 547,282
Change -0.79%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-05-25 Upgrade
Raymond James
Outperform → Strong Buy
$85 → $65
Sep-06-24 Upgrade
Barclays
Equal Weight → Overweight
$57 → $79
Mar-06-24 Initiated
Barclays
Equal Weight
$48
Aug-31-23 Initiated
Truist
Buy
$40
Mar-31-23 Initiated
CJS Securities
Market Outperform
$30
Mar-03-23 Upgrade
Raymond James
Mkt Perform → Outperform
$30
Aug-12-21 Initiated
Barclays
Overweight
$39
Mar-15-19 Downgrade
Raymond James
Strong Buy → Outperform
$16 → $17.50
Mar-14-18 Initiated
Raymond James
Strong Buy
Aug-22-17 Upgrade
Jefferies
Hold → Buy
Jun-02-16 Initiated
Sterne Agee CRT
Neutral
Apr-15-16 Initiated
Sidoti
Buy
$9
Mar-17-09 Reiterated
Jefferies & Co
Buy
$12 → $4
Oct-15-08 Initiated
RBC Capital Mkts
Sector Perform
$4
Jul-14-08 Upgrade
Stanford Research
Hold → Buy
$9
Apr-02-08 Upgrade
Morgan Keegan
Mkt Perform → Outperform
Mar-14-08 Downgrade
Morgan Keegan
Outperform → Mkt Perform
Dec-19-07 Initiated
Leerink Swann
Outperform
Dec-07-07 Initiated
Stanford Research
Hold
$10.40
Nov-07-07 Initiated
Morgan Keegan
Outperform
Show Previous Ratings
May-13-25 11:28AM
03:06AM
12:52AM
(Thomson Reuters StreetEvents)
May-12-25 08:35AM
05:55AM
(Associated Press Finance)
04:00PM
Loading…
May-11-25 04:00PM
May-09-25 09:21AM
06:00AM
May-08-25 11:54AM
May-07-25 07:35AM
May-01-25 12:55PM
Apr-29-25 11:30AM
11:12AM
Apr-27-25 02:22PM
Apr-24-25 05:50PM
01:30PM
Loading…
01:30PM
06:00AM
Apr-22-25 07:55AM
Apr-17-25 12:06PM
Apr-15-25 04:01PM
Apr-14-25 09:49AM
Mar-26-25 05:42PM
05:05AM
Mar-21-25 08:30AM
Mar-14-25 05:08AM
Mar-13-25 06:00AM
Mar-07-25 09:45AM
Mar-01-25 05:26AM
(Thomson Reuters StreetEvents)
02:12AM
Feb-27-25 06:20PM
05:34PM
Loading…
05:34PM
(Associated Press Finance)
05:23PM
04:20PM
07:10AM
Feb-26-25 08:19AM
07:57AM
06:00AM
01:00AM
Feb-25-25 06:00AM
Feb-21-25 10:00AM
Feb-14-25 06:00AM
Feb-01-25 04:41PM
Jan-23-25 06:57AM
Jan-15-25 10:26AM
Jan-08-25 06:00AM
Dec-20-24 03:30PM
(Investor's Business Daily)
Dec-04-24 01:30PM
Dec-02-24 06:00AM
06:00AM
Dec-01-24 12:00PM
07:00AM
Nov-30-24 07:20AM
06:05AM
Nov-29-24 09:43AM
06:00AM
Nov-22-24 11:00AM
Nov-20-24 09:15AM
Nov-12-24 06:00AM
03:53AM
(Thomson Reuters StreetEvents)
Nov-11-24 12:20PM
(Medical Device Network) +19.10%
09:02AM
08:14AM
06:00AM
05:04AM
(Associated Press Finance)
Nov-10-24 04:15PM
Nov-08-24 07:04AM
Nov-07-24 06:00AM
Nov-04-24 10:00AM
Oct-25-24 06:00AM
Oct-09-24 05:49PM
12:45PM
Sep-17-24 04:05PM
08:00AM
Sep-12-24 06:00AM
Sep-05-24 06:00AM
Sep-03-24 06:00AM
Aug-22-24 11:42PM
Aug-12-24 08:46AM
Aug-07-24 10:30PM
08:05PM
07:03PM
(Associated Press Finance)
04:10PM
Aug-01-24 10:01AM
Jul-29-24 08:25AM
Jul-20-24 09:51AM
Jul-16-24 06:00AM
Jun-20-24 07:00PM
06:00AM
Jun-19-24 02:39AM
Jun-15-24 03:14AM
Jun-14-24 03:05AM
Jun-13-24 02:45AM
02:45AM
Jun-11-24 07:01PM
07:01PM
10:50AM
06:00AM
Jun-07-24 06:00AM
Jun-06-24 09:15AM
Jun-05-24 12:45PM
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lawrence L. Levitt Director May 16 '25 Proposed Sale 61.09 5,000 305,439 May 16 07:17 PM STEPHEN M FORTHUBER Officer May 16 '25 Proposed Sale 60.48 18,820 1,138,299 May 16 04:10 PM HAMES NORMAN R Pres and COO-West Operations May 15 '25 Sale 60.00 5,536 332,160 249,183 May 15 08:43 PM HAMES NORMAN R Pres and COO-West Operations May 15 '25 Sale 60.00 2,911 174,660 24,889 May 15 08:43 PM Norman R. Hames Member of Immediate Family of May 15 '25 Proposed Sale 60.00 2,911 174,661 May 15 08:43 PM Norman R. Hames President & COO-West Operation May 15 '25 Proposed Sale 60.00 5,536 332,160 May 15 08:43 PM Patel Mital EVP of Fin Planning, CAO Apr 04 '25 Option Exercise 8.61 50,340 433,315 230,138 Apr 08 08:00 AM Norman R. Hames President & COO-West Operation Mar 17 '25 Proposed Sale 49.42 15,000 741,295 Mar 19 08:51 PM HAMES NORMAN R Pres and COO-West Operations Mar 19 '25 Sale 50.22 5,000 251,100 251,959 Mar 19 08:49 PM HAMES NORMAN R Pres and COO-West Operations Mar 17 '25 Sale 49.79 5,000 248,950 261,959 Mar 19 08:49 PM HAMES NORMAN R Pres and COO-West Operations Mar 18 '25 Sale 48.25 5,000 241,250 256,959 Mar 19 08:49 PM SWARTZ DAVID L Director Mar 07 '25 Sale 50.84 25,000 1,271,000 174,067 Mar 11 09:31 PM David Swartz Director Mar 07 '25 Proposed Sale 51.32 25,000 1,283,000 Mar 11 09:30 PM Wesdorp Cornelis Officer Mar 05 '25 Proposed Sale 51.63 5,000 258,140 Mar 07 08:58 PM Wesdorp Cornelis Pres & CEO, Digital Health Mar 05 '25 Sale 52.58 2,000 105,160 58,995 Mar 07 07:18 PM Wesdorp Cornelis Pres & CEO, Digital Health Mar 06 '25 Sale 51.23 2,000 102,460 56,995 Mar 07 07:18 PM Wesdorp Cornelis Pres & CEO, Digital Health Mar 07 '25 Sale 50.52 1,000 50,520 55,995 Mar 07 07:18 PM HAMES NORMAN R Pres and COO-West Operations Mar 05 '25 Option Exercise 10.11 11,956 120,828 266,197 Mar 06 09:04 PM Katz David Jeffrey EVP and Chief Legal Officer Nov 25 '24 Sale 81.65 12,300 1,004,252 62,909 Nov 27 05:00 PM Katz David Jeffrey Officer Nov 25 '24 Proposed Sale 82.04 12,300 1,009,092 Nov 25 10:20 AM Jayanathan Ranjan Chief Information Officer Nov 19 '24 Sale 80.00 38,557 3,084,560 192,724 Nov 21 05:00 PM Jayanathan Ranjan Officer Nov 14 '24 Proposed Sale 90.00 38,557 3,470,130 Nov 14 10:35 AM Katz David Jeffrey EVP and Chief Legal Officer Oct 01 '24 Option Exercise 29.44 10,188 299,935 75,209 Oct 02 05:41 PM Murdock Michael N EVP, Mergers and Acquisitions Aug 21 '24 Sale 62.78 15,000 941,702 48,144 Aug 22 05:12 PM Murdock Michael N Officer Aug 20 '24 Proposed Sale 62.50 15,000 937,500 Aug 20 03:28 PM Patel Mital EVP, Chief Admin Officer Jun 18 '24 Sale 59.00 29,800 1,758,200 202,146 Jun 20 05:00 PM Patel Mital EVP, Chief Admin Officer Jun 17 '24 Sale 60.00 10,200 612,000 231,946 Jun 20 05:00 PM SPURLOCK GREGORY E. Director Jun 18 '24 Sale 59.75 7,167 428,228 2,591 Jun 18 06:23 PM SPURLOCK GREGORY E. Director Jun 17 '24 Sale 59.75 7,167 428,228 9,758 Jun 18 06:23 PM Murdock Michael N EVP, Mergers and Acquisitions Jun 12 '24 Sale 62.51 10,000 625,100 63,144 Jun 14 05:00 PM Levitt Lawrence L Director Jun 14 '24 Sale 57.77 4,000 231,080 172,657 Jun 14 05:00 PM Forthuber Stephen M Pres & COO-Eastern Operations Jun 12 '24 Sale 62.33 40,000 2,493,200 523,561 Jun 13 05:30 PM Sorensen Alma Gregory EVP, Chief Science Officer Jun 12 '24 Sale 62.34 10,000 623,400 1,239,205 Jun 13 05:30 PM Sorensen Alma Gregory EVP, Chief Science Officer Jun 11 '24 Sale 61.24 5,000 306,200 1,249,205 Jun 13 05:30 PM SWARTZ DAVID L Director Jun 10 '24 Sale 60.43 20,934 1,265,042 200,542 Jun 12 05:36 PM SWARTZ DAVID L Director Jun 12 '24 Sale 62.42 4,066 253,800 196,476 Jun 12 05:36 PM STOLPER MARK EVP, Chief Financial Officer Jun 10 '24 Sale 61.27 25,000 1,531,750 80,398 Jun 12 05:36 PM Levitt Lawrence L Director Jun 10 '24 Sale 60.85 16,000 973,600 174,066 Jun 12 05:35 PM HAMES NORMAN R Pres and COO-West Operations Jun 11 '24 Sale 61.40 35,000 2,149,000 245,919 Jun 12 05:33 PM HAMES NORMAN R Pres and COO-West Operations Jun 12 '24 Sale 63.08 18,597 1,173,099 227,322 Jun 12 05:33 PM HAMES NORMAN R Pres and COO-West Operations Jun 10 '24 Sale 61.15 15,000 917,250 280,919 Jun 12 05:33 PM HAMES NORMAN R Pres and COO-West Operations Jun 10 '24 Sale 61.09 5,000 305,450 24,889 Jun 12 05:33 PM Katz David Jeffrey EVP and Chief Legal Officer Jun 07 '24 Sale 61.26 16,400 1,004,664 65,441 Jun 11 05:00 PM Gordon Christine Nayoma Director Jun 07 '24 Sale 61.30 3,000 183,900 12,379 Jun 11 05:00 PM Gordon Christine Nayoma Director Jun 10 '24 Sale 61.03 1,500 91,545 10,879 Jun 11 05:00 PM